SCHEMBL842050

SCHEMBL842050

Nc1nc2c(N)nc3cccnc3c2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.42
NUDT1 P36639 2/20 0.42
CDK1 P06493 1/20 0.42
CDK2 P24941 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
ALDH1A1 P00352 3/20 0.38
CDK5 Q00535 3/20 0.38
CDK5R1 Q15078 3/20 0.38
DYRK1A Q13627 3/20 0.38
KMT2A Q03164 2/20 0.38
MASP2 O00187 1/20 0.38
MEN1 O00255 1/20 0.38
AOC3 Q16853 1/20 0.38
ULK1 O75385 1/20 0.38
CDK7 P50613 1/20 0.38
PRKCE Q02156 1/20 0.38
CAMK2G Q13555 1/20 0.38
RPS6KA1 Q15418 1/20 0.38
AAK1 Q2M2I8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4390007 0.84 PRMT5 (0.41) PRMT5NUDT1CDK1CDK2MKNK1
SCHEMBL4390168 0.78 CSNK2A1 (0.40) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL311681 0.77 PRMT5 (0.42) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL30413516 0.77 PRMT5 (0.42) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL1490778 0.77 NUDT1 (0.42) PRMT5NUDT1CDK1CDK2MKNK1
SCHEMBL787142 0.76 QTRT1 (0.51) NUDT1ALDH1A1KMT2AMASP2MEN1
SCHEMBL2059193 0.74 TLR8 (0.43) PRMT5CDK1CDK2MKNK1MKNK2
SCHEMBL1635226 0.73 NUDT1 (0.42) NUDT1ALDH1A1CDK5CDK5R1DYRK1A
SCHEMBL5317312 0.73 TLR8 (0.36) PRMT5NUDT1CDK1CDK2MKNK1
SCHEMBL4570270 0.72 QTRT1 (0.56) PRMT5NUDT1ALDH1A1KMT2AMASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143270-B2 2-amino 1H-in-imidazo ring systems and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-03-27 US disclosed
EP-1784180-A4 2-AMINO 1H IMIDAZO RING SYSTEMS AND METHODS 3M INNOVATIVE PROPERTIES CO (US) 2009-07-22 EP disclosed
US-20090023720-A1 2-Amino 1H-Imidazo Ring Systems and Methods 3M INNOVATIVE PROPERTIES COMPANY 2009-01-22 US disclosed
EP-1784180-A2 2-AMINO 1H IMIDAZO RING SYSTEMS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-05-16 EP disclosed
WO-2006029115-A2 2-AMINO 1H IMIDAZO RING SYSTEMS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023720-A1 2-Amino 1H-Imidazo Ring Systems and Methods IL2, IL2RA, IL4I1 PRMT5 252/4885NUDT1 781/4885CDK1 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.